samedan logo

 
 
spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Antares Vision Strengthens Traceability Position by Acquiring Assets of Adents

Antares Vision




Travagliato (BS), 12nd November 2020

Antares Vision announces that it has been selected by the French judicial authority as the winner of the tender for the purchase - directly or indirectly through its subsidiaries - of the assets of the French company Adents High Tech International ("Adents").

Adents, currently in liquidation, has developed a traceability and serialization software platform for the management and exchange of data between companies and regulatory authorities (level 5) and a complete offer of cloud services (both single-tenant and multi-tenant). Mainly focused on the pharmaceutical sector, the platform is strategic in other sectors such as food, beverage (especially in the champagne niche) and luxury goods.



The transaction will allow Antares Vision to expand its portfolio of software solutions able to track and trace the end-to-end supply chain, enabling all the supply chain players (distributors, CMO's, 3PLs, hospitals and pharmacies) to be compliant to the traceability of medicines regulations and able to ensure the transparency and sustainability of the production and distribution chain in several industries.

In addition, through the transaction, some Adents’s staff will be hired and the R&D team will also be strengthen by including highly specialized resources in the Antares Vision staff.

Thus, Antares Vision will enhance its service capacity with greater capillarity in technical and sales support, as well as its international presence, mainly in France, UK, Ireland, Sweden and in the United States.

Emidio Zorzella, Chairman and CEO of Antares Vision: “We are very satisfied with this operation which will allow us to continue to strengthen our strategy and to implement a complete, digital and scalable solution for the supply chain traceability. The operation is particularly strategic in terms of acquiring new software solutions, new skills, strengthening the geographical presence and expanding into new industries. The expertise in traceability for beverage will allow us to accelerate our diversification in new industries, as in the champagne segment."

The closing will take place within the maximum term of 2 months; the value of the transaction, equal to 1.5 million euros, will be paid in cash. It should be noted that the transaction is not significant pursuant to art. 12 of the AIM Italia Rules for Companies, none of the applicable class tests is exceeding 25%.
phone +39-030-7283500
email info@antaresvision.com
web https://www.antaresvision.com/
email Via Del Ferro, 16, 25039, Travagliato, Brescia
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Calyx Supports Breakthrough Therapy Approvals for Oncology Treatments

Calyx, the eClinical and regulatory solutions and services provider most relied on for solving complex data challenges in clinical research, today announced that its Medical Imaging and other eClinical solutions supported half of the oncology treatments approved by the FDA as Breakthrough Therapies in the past two years.
More info >>


White Papers

Personalised Medicine - Pharma and Dx Firms Share Wider Horizons

DiagnostikNet-BB

Personalised medicine might be a popular catch-phrase at the moment, but the term often causes confusion, as there is still no uniform definition for it. The expression can include areas as diverse as the measurement of individual risk, early detection using biomarker testing, stratification of patients suffering from a disease and predictions about its course.
More info >>

Industry Events

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

8-11 February 2021, Vienna, Austria

In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 8-11 Feb 2021. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement